J Med Microbiol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tissi, L.
Right arrow Articles by Orefici, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tissi, L.
Right arrow Articles by Orefici, G.
Agricola
Right arrow Articles by Tissi, L.
Right arrow Articles by Orefici, G.

The Journal of Medical Microbiology, Vol 47, Issue 8 717-723, Copyright © 1998 by Society for General Microbiology


JOURNAL ARTICLE

Role of group B streptococcal capsular polysaccharides in the induction of septic arthritis

L. Tissi, C. von Hunolstein, F. Bistoni, M. Marangi, L. Parisi and G. Orefici
Department of Experimental Medicine and Biochemical Sciences, University of Perugia, Italy.

The ability of different serotypes of group B streptococci (GBS) to induce septic arthritis in mice was compared. Types II, III, IV, V, VI and VII GBS were investigated. A highly capsulate strain of type III GBS, COH1, and its mutants, COH1-11 (lacking capsular sialic acid) and COH1-13 (non-capsulate), obtained by transposon insertional mutagenesis, were used to assess the role of type-specific polysaccharide on the induction of arthritis. At an intravenous dose of 10(7) cfu/mouse, reference strains of types II, III, IV, VI and VII and type III strain COH1 induced arthritis with an incidence ranging from 70 to 90%. For type V and strain COH1-11, 10(8) cfu/mouse was required to obtain a 50% incidence of arthritis; lesions were not evident with strain COH1-13. The presence of the capsule played a major role in the induction of GBS septic arthritis. The presence and amount of sialic acid in capsular polysaccharide influenced the incidence of articular lesions. The bacterial dose affected the manifestations of arthritis; the less virulent strains of GBS also induced articular lesions when an adequate number of micro-organisms reached the joints.


This article has been cited by other articles:


Home page
Infect. Immun.Home page
M. Puliti, C. von Hunolstein, C. Verwaerde, F. Bistoni, G. Orefici, and L. Tissi
Regulatory Role of Interleukin-10 in Experimental Group B Streptococcal Arthritis
Infect. Immun., June 1, 2002; 70(6): 2862 - 2868.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Puliti, F. Bistoni, C. von Hunolstein, G. Orefici, and L. Tissi
Severity of Group B Streptococcal Arthritis in Selected Strains of Laboratory Mice
Infect. Immun., January 1, 2001; 69(1): 551 - 555.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
L. Tissi, M. Puliti, R. Barluzzi, G. Orefici, C. von Hunolstein, and F. Bistoni
Role of Tumor Necrosis Factor Alpha, Interleukin-1beta , and Interleukin-6 in a Mouse Model of Group B Streptococcal Arthritis
Infect. Immun., September 1, 1999; 67(9): 4545 - 4550.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 1998 Society for General Microbiology.